This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 342026
Submitted by lobbyist on: August 1, 2013 10:17:18 AM
Accepted by Registrar on: August 1, 2013 10:25:20 AM
Designated Filer Information
| Warren, Scott |
| 85 Enterprise Blvd | |
|
Markham, ON, L6G 0B5
|
905-940-7175 |
| Canada |
Organization Information
| Allergan, Inc |
| Allergan is a specialty pharmaceutical/medical device compnay dedicated to improving patients lives |
| 85 Enterprise Blvd | |
|
Markham, ON, L6G 0B5
|
905-940-7175 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| Allergan, Inc |
2525 Dupont Dr
Irvine, CA 92612 United States of America |
Phone: |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| August 1, 2013 | |
| March 6, 2014 |
Organization's In-House Lobbyists
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Establish meetings with Drug Benefit Branch to negotiate/change/modify current and future drug listings on BC formulary
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | August 1, 2013 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Negotiate the addition of BOTOX for Neurogenic Detrusor Overactivity to the BC drug formulary
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | August 1, 2013 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Working to get BOTOX for Neurogenic Detrusor Overactivity funded for public formulary patient access
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | August 1, 2013 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Working to get BOTOX for Neurogenic Detrusor Overactivity funded for public formulary patient access
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | August 1, 2013 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Working to get BOTOX for Neurogenic Detrusor Overactivity funded for public formulary patient access
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | August 1, 2013 |